General Information of the Compound
| Compound ID |
CP0294069
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5-Chloro-2-pyridin-2-yl-1H-benzoimidazole
Show/Hide
|
||||||||||||||||||
| Synonyms |
1H-Benzimidazole, 6-chloro-2-(2-pyridinyl)-
2-(2-Pyridyl)-5-chloro-1H-benzoimidazole
5-chlor-2-(2-pyridinyl)-1h-benzimidazol
5-chloro-2-(pyridin-2-yl)-1H-benzo[d]imidazole
5-chloro-2-pyridin-2-yl-3H-benzoimidazole
6-chloro-2-(pyridin-2-yl)-1H-1,3-benzodiazole
6-chloro-2-pyridin-2-yl-1H-benzimidazole
63053-15-6
AC1L4JHX
AC1Q3S8V
AKOS005256857
AKOS008957084
BDBM50180732
CHEMBL166127
CTK2F4016
KS-00001PG4
MCULE-2896710700
MolPort-006-709-924
NE28766
SCHEMBL124391
ZINC13679488
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C12H8ClN3
|
||||||||||||||||||
| Molecular Weight |
229.67
|
||||||||||||||||||
| Canonical SMILES |
Clc1ccc2nc([nH]c2c1)-c1ccccn1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C12H8ClN3/c13-8-4-5-9-11(7-8)16-12(15-9)10-3-1-2-6-14-10/h1-7H,(H,15,16)
Show/Hide
|
||||||||||||||||||
| InChIKey |
AIASBFLKLNIZOK-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
63053-15-6
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound